Avalo Therapeutics Correlations

AVTX Stock  USD 10.13  0.48  4.97%   
The current 90-days correlation between Avalo Therapeutics and Aerovate Therapeutics is -0.04 (i.e., Good diversification). The correlation of Avalo Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Avalo Therapeutics Correlation With Market

Good diversification

The correlation between Avalo Therapeutics and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Avalo Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avalo Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Avalo Stock please use our How to Invest in Avalo Therapeutics guide.

Moving together with Avalo Stock

  0.61MLYS Mineralys Therapeutics,PairCorr
  0.64BAC Bank of America Fiscal Year End 10th of January 2025 PairCorr
  0.72AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.61INTC Intel Fiscal Year End 23rd of January 2025 PairCorr

Moving against Avalo Stock

  0.79MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.76MTEM Molecular TemplatesPairCorr
  0.71NKTX Nkarta IncPairCorr
  0.67AGL agilon healthPairCorr
  0.65TPST Tempest TherapeuticsPairCorr
  0.63ME 23Andme HoldingPairCorr
  0.61JNJ Johnson Johnson Sell-off TrendPairCorr
  0.55IPSC Century TherapeuticsPairCorr
  0.54VALN Valneva SE ADRPairCorr
  0.53A Agilent Technologies Earnings Call TomorrowPairCorr
  0.46PFE Pfizer Inc Aggressive PushPairCorr
  0.45BACK IMAC HoldingsPairCorr
  0.45CYRX CryoportPairCorr
  0.35TCHH Trustcash HoldingsPairCorr
  0.31ROIV Roivant SciencesPairCorr
  0.78EC Ecopetrol SA ADRPairCorr
  0.76KO Coca Cola Aggressive PushPairCorr
  0.72HYMTF Hyundai MotorPairCorr
  0.71PG Procter GamblePairCorr
  0.67TLK Telkom Indonesia TbkPairCorr
  0.57SHG Shinhan FinancialPairCorr
  0.51WF Woori Financial GroupPairCorr
  0.5BA Boeing Fiscal Year End 29th of January 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ALXOANAB
AVTEACLX
ANEBANAB
PMVPAVTE
MOLNACRV
ANEBGPCR
  
High negative correlations   
AVTEANAB
ALXOAVTE
ALXOACLX
ACLXANAB
ANEBAVTE
PMVPANAB

Risk-Adjusted Indicators

There is a big difference between Avalo Stock performing well and Avalo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Avalo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANAB  3.29 (1.01) 0.00 (0.21) 0.00 
 5.30 
 35.57 
ACLX  2.46  0.23  0.12  0.22  2.74 
 6.28 
 15.13 
GPCR  2.96 (0.25) 0.00 (0.24) 0.00 
 8.18 
 24.50 
AVTE  2.55  0.49  0.19  0.61  2.13 
 5.58 
 19.11 
ALXO  3.50 (0.92) 0.00 (0.31) 0.00 
 7.53 
 22.71 
ANEB  5.20 (0.27) 0.00 (0.03) 0.00 
 8.85 
 76.00 
ACRV  2.84 (0.57) 0.00 (0.20) 0.00 
 7.66 
 22.84 
PMVP  1.67  0.02 (0.03) 0.28  2.12 
 3.75 
 13.98 
MOLN  4.66 (0.26) 0.00 (0.11) 0.00 
 9.61 
 52.92 
MLYS  2.68 (0.08) 0.03  0.09  3.37 
 6.27 
 20.98 

Avalo Therapeutics Corporate Management

Blake MDScientific AdvisorProfile
Barbara SlusherFounder BoardProfile
Maxim CFAVP RelationsProfile
Stephen ThomasVP DiscoveryProfile
Christopher SullivanChief OfficerProfile